John N Drye, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 10 Kruger Rd, Plains, MT 59859 Phone: 406-826-4816 Fax: 406-826-4898 |
Dr. Barbara Steward, DO Family Medicine Medicare: Medicare Enrolled Practice Location: 10 Kruger Road, Plains, MT 59859 Phone: 406-826-4800 |
Dr. Mark Jay Catalanello, M.D. Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 11 Paradox Ln, Plains, MT 59859 Phone: 406-826-5064 Fax: 406-826-1283 |
Dr. Jessica Kealoha Valentine, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 10 Kruger Rd, Plains, MT 59859 Phone: 406-826-4800 Fax: 406-826-4811 |
Dr. Glenn Alan Wielenga, M.D. Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 807 S. 5th Ave, Plains, MT 59859 Phone: 406-826-3141 Fax: 406-826-5505 |
Dr. Rhonda Elaine Damschen, M.D. Family Medicine Medicare: Medicare Enrolled Practice Location: 11 Paradox Ln, Plains, MT 59859 Phone: 406-826-5064 Fax: 406-826-1283 |
News Archive
The results show that Oraya Therapy is effective in maintaining vision with reduced injections for patients at different stages of their disease—from chronic patients in discontinuous treatment to treatment-naive patients with new diagnosis—and following different treatment pathways.
In formerly depressed South Texas, gas flares from the fracking boom can be seen from outer space. While Texas has a Division of Workers' Compensation, it is the only state that doesn't require any private employer to carry workers' compensation insurance or a private equivalent, so more than 500,000 people have no occupational benefits when they get injured at work. That means they often rely on charities or taxpayers to pay for their care (Root, 6/29)
Scientists have made a major breakthrough in understanding the workings of the cellular machinery involved in a host of inflammatory diseases.
Ligand Pharmaceuticals Incorporated partner GlaxoSmithKline announced that today, the European Medicines Agency's Committee for Medicinal Products for Human Use issued a positive opinion recommending marketing authorization for GSK's REVOLADE (eltrombopag) as a treatment for low platelet counts (thrombocytopenia) in adult patients with chronic hepatitis C infection, where the degree of thrombocytopenia is the main factor preventing the initiation or limiting the ability to maintain optimal interferon-based therapy
Richard Shields, Ph.D., University of Iowa professor in the Graduate Program in Physical Therapy and Rehabilitation Science, can foresee a time when it might be possible to cure spinal cord injury (SCI).
› Verified 3 days ago